MarketPeel
Insider Trading Intelligence
Pricing
…
TK

Tasos Konidaris

AMRX
EXECUTIVE VICE PRESIDENT & CFO · AMNEAL PHARMACEUTICALS, INC. · CIK 0001320982
FILING MIX · LIFETIME47%/53%
BUYS
34
SELLS
38
TOTAL VALUE
$11.55M
COMPANIES
1
ACTIVE SINCE
Mar 2020
HOLDINGS NOW
471,469
AVG SELL PX
$10.00
TRADE KIND
SHOWING 72 / 72
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
4 backtested trades · 8 horizons · 7 pending
Forward-return performance of every backtestable P/S trade by Tasos Konidaris, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d4+25.00%+0.52%-1.59%+2.11%+2.07%—
14d4+50.00%-0.06%-0.40%+0.34%+0.48%—
30d4+25.00%-0.31%-1.62%+1.31%+2.66%—
60d4+25.00%-1.38%+1.37%-2.75%+0.42%—
90d4+25.00%+14.70%+4.71%+9.99%+19.12%—
180d4+0.00%+43.50%+8.15%+35.35%+47.44%—
1y4(3 pending)+0.00%+47.83%+17.20%+30.62%+30.62%—
2y4(4 pending)——————
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
AMRX · 471,469 shares · as of Mar 4, 2026
0198,265396,531594,796793,061202120222023202420252026SHARES HELD
Trading cadence · quarterly flow
BUY ● SELL ●
2020
2020
2020
2020
2021
2021
2021
2021
2022
2022
2022
2022
2023
2023
2023
2023
2024
2024
2024
2024
2025
2025
2025
2025
2026
FLOW · 34 buys / 38 sellsCOVERAGE · 25 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
AMRX
AMNEAL PHARMACEUTICALS, INC.
SALE
Executive Vice President & CFO
49,982——87,963Mar 4, 2026Mar 5, 2026 ↗View →
AMRX
AMNEAL PHARMACEUTICALS, INC.
SALE
Executive Vice President & CFO
22,035$13.30$293.1K449,434Mar 4, 2026Mar 5, 2026 ↗View →
AMRX
AMNEAL PHARMACEUTICALS, INC.
PURCHASE
Executive Vice President & CFO
43,982——471,469Mar 4, 2026Mar 5, 2026 ↗View →
AMRX
AMNEAL PHARMACEUTICALS, INC.
SALE
Executive Vice President & CFO
458,716——0Mar 3, 2026Mar 5, 2026 ↗View →
AMRX
AMNEAL PHARMACEUTICALS, INC.
SALE
Executive Vice President & CFO
16,182$13.31$215.4K151,260Mar 3, 2026Mar 5, 2026 ↗View →
AMRX
AMNEAL PHARMACEUTICALS, INC.
PURCHASE
Executive Vice President & CFO
45,290——167,442Mar 3, 2026Mar 5, 2026 ↗View →
AMRX
AMNEAL PHARMACEUTICALS, INC.
PURCHASE
Executive Vice President & CFO
458,716——657,304Mar 3, 2026Mar 5, 2026 ↗View →
AMRX
AMNEAL PHARMACEUTICALS, INC.
SALE
Executive Vice President & CFO
28,538——85,617Mar 3, 2026Mar 5, 2026 ↗View →
AMRX
AMNEAL PHARMACEUTICALS, INC.
PURCHASE
Executive Vice President & CFO
28,538——212,886Mar 3, 2026Mar 5, 2026 ↗View →
AMRX
AMNEAL PHARMACEUTICALS, INC.
SALE
Executive Vice President & CFO
229,817$13.31$3.06M427,487Mar 3, 2026Mar 5, 2026 ↗View →
AMRX
AMNEAL PHARMACEUTICALS, INC.
PURCHASE
Executive Vice President & CFO
57,339——208,599Mar 3, 2026Mar 5, 2026 ↗View →
AMRX
AMNEAL PHARMACEUTICALS, INC.
SALE
Executive Vice President & CFO
24,251$13.31$322.8K184,348Mar 3, 2026Mar 5, 2026 ↗View →
AMRX
AMNEAL PHARMACEUTICALS, INC.
SALE
Executive Vice President & CFO
45,290——0Mar 3, 2026Mar 5, 2026 ↗View →
AMRX
AMNEAL PHARMACEUTICALS, INC.
SALE
Executive Vice President & CFO
14,298$13.31$190.3K198,588Mar 3, 2026Mar 5, 2026 ↗View →
AMRX
AMNEAL PHARMACEUTICALS, INC.
SALE
Executive Vice President & CFO
57,339——57,340Mar 3, 2026Mar 5, 2026 ↗View →
AMRX
AMNEAL PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
72,622——72,622Mar 2, 2026Mar 3, 2026 ↗View →
AMRX
AMNEAL PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
72,622——72,622Mar 2, 2026Mar 3, 2026 ↗View →
AMRX
AMNEAL PHARMACEUTICALS, INC.
SALE
Executive Vice President & CFO
219,159$9.43$2.07M122,152Aug 15, 2025Aug 15, 2025 ↗View →
AMRX
AMNEAL PHARMACEUTICALS, INC.
SALE
Executive Vice President & CFO
119,206$9.30$1.11M341,311Aug 14, 2025Aug 15, 2025 ↗View →
AMRX
AMNEAL PHARMACEUTICALS, INC.
SALE
Executive Vice President & CFO
161,365$9.22$1.49M460,517Aug 13, 2025Aug 15, 2025 ↗View →
AMRX
AMNEAL PHARMACEUTICALS, INC.
SALE
Executive Vice President & CFO
100,000$8.91$891.0K621,882Mar 5, 2025Mar 6, 2025 ↗View →
AMRX
AMNEAL PHARMACEUTICALS, INC.
SALE
Executive Vice President & CFO
22,497$8.84$198.9K721,882Mar 4, 2025Mar 5, 2025 ↗View →
AMRX
AMNEAL PHARMACEUTICALS, INC.
SALE
Executive Vice President & CFO
43,981——131,945Mar 4, 2025Mar 5, 2025 ↗View →
AMRX
AMNEAL PHARMACEUTICALS, INC.
PURCHASE
Executive Vice President & CFO
43,981——744,379Mar 4, 2025Mar 5, 2025 ↗View →
AMRX
AMNEAL PHARMACEUTICALS, INC.
PURCHASE
Executive Vice President & CFO
181,159——793,061Mar 3, 2025Mar 5, 2025 ↗View →
AMRX
AMNEAL PHARMACEUTICALS, INC.
PURCHASE
Executive Vice President & CFO
57,340——636,276Mar 3, 2025Mar 5, 2025 ↗View →
AMRX
AMNEAL PHARMACEUTICALS, INC.
SALE
Executive Vice President & CFO
16,373$8.76$143.4K578,936Mar 3, 2025Mar 5, 2025 ↗View →
AMRX
AMNEAL PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
228,310——228,310Mar 3, 2025Mar 5, 2025 ↗View →
AMRX
AMNEAL PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
114,155——114,154Mar 3, 2025Mar 5, 2025 ↗View →
AMRX
AMNEAL PHARMACEUTICALS, INC.
PURCHASE
Executive Vice President & CFO
45,290——595,309Mar 3, 2025Mar 5, 2025 ↗View →
AMRX
AMNEAL PHARMACEUTICALS, INC.
SALE
Executive Vice President & CFO
24,374$8.76$213.5K611,902Mar 3, 2025Mar 5, 2025 ↗View →
AMRX
AMNEAL PHARMACEUTICALS, INC.
SALE
Executive Vice President & CFO
57,340——114,679Mar 3, 2025Mar 5, 2025 ↗View →
AMRX
AMNEAL PHARMACEUTICALS, INC.
SALE
Executive Vice President & CFO
45,290——45,290Mar 3, 2025Mar 5, 2025 ↗View →
AMRX
AMNEAL PHARMACEUTICALS, INC.
SALE
Executive Vice President & CFO
92,663$8.76$811.7K700,398Mar 3, 2025Mar 5, 2025 ↗View →
AMRX
AMNEAL PHARMACEUTICALS, INC.
SALE
Executive Vice President & CFO
181,159——0Mar 3, 2025Mar 5, 2025 ↗View →
AMRX
AMNEAL PHARMACEUTICALS, INC.
SALE
Executive Vice President & CFO
36,197——0Mar 1, 2025Mar 4, 2025 ↗View →
AMRX
AMNEAL PHARMACEUTICALS, INC.
SALE
Executive Vice President & CFO
13,494$8.67$117.0K550,019Mar 1, 2025Mar 4, 2025 ↗View →
AMRX
AMNEAL PHARMACEUTICALS, INC.
PURCHASE
Executive Vice President & CFO
36,197——563,513Mar 1, 2025Mar 4, 2025 ↗View →
AMRX
AMNEAL PHARMACEUTICALS, INC.
PURCHASE
Executive Vice President & CFO
87,720——558,106Mar 12, 2024Mar 14, 2024 ↗View →
AMRX
AMNEAL PHARMACEUTICALS, INC.
SALE
Executive Vice President & CFO
30,790$5.31$163.5K527,316Mar 12, 2024Mar 14, 2024 ↗View →
AMRX
AMNEAL PHARMACEUTICALS, INC.
SALE
Executive Vice President & CFO
87,720——0Mar 12, 2024Mar 14, 2024 ↗View →
AMRX
AMNEAL PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
351,852——351,852Mar 4, 2024Mar 5, 2024 ↗View →
AMRX
AMNEAL PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
175,926——175,926Mar 4, 2024Mar 5, 2024 ↗View →
AMRX
AMNEAL PHARMACEUTICALS, INC.
SALE
Executive Vice President & CFO
20,126$5.47$110.1K470,386Mar 3, 2024Mar 5, 2024 ↗View →
AMRX
AMNEAL PHARMACEUTICALS, INC.
PURCHASE
Executive Vice President & CFO
57,339——490,512Mar 3, 2024Mar 5, 2024 ↗View →
AMRX
AMNEAL PHARMACEUTICALS, INC.
SALE
Executive Vice President & CFO
57,339——172,019Mar 3, 2024Mar 5, 2024 ↗View →
AMRX
AMNEAL PHARMACEUTICALS, INC.
SALE
Executive Vice President & CFO
45,290——90,580Mar 3, 2024Mar 5, 2024 ↗View →
AMRX
AMNEAL PHARMACEUTICALS, INC.
SALE
Executive Vice President & CFO
15,897$5.47$87.0K433,173Mar 3, 2024Mar 5, 2024 ↗View →
AMRX
AMNEAL PHARMACEUTICALS, INC.
PURCHASE
Executive Vice President & CFO
45,290——449,070Mar 3, 2024Mar 5, 2024 ↗View →
AMRX
AMNEAL PHARMACEUTICALS, INC.
SALE
Executive Vice President & CFO
36,197——36,197Mar 1, 2024Mar 5, 2024 ↗View →
AMRX
AMNEAL PHARMACEUTICALS, INC.
SALE
Executive Vice President & CFO
13,257$5.47$72.5K403,780Mar 1, 2024Mar 5, 2024 ↗View →
AMRX
AMNEAL PHARMACEUTICALS, INC.
PURCHASE
Executive Vice President & CFO
36,197——417,037Mar 1, 2024Mar 5, 2024 ↗View →
AMRX
AMNEAL PHARMACEUTICALS, INC.
SALE
Executive Vice President & CFO
87,719——87,720Mar 12, 2023Mar 14, 2023 ↗View →
AMRX
AMNEAL PHARMACEUTICALS, INC.
PURCHASE
Executive Vice President & CFO
87,719——380,840Mar 12, 2023Mar 14, 2023 ↗View →
AMRX
AMNEAL PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
229,358——229,358Mar 3, 2023Mar 7, 2023 ↗View →
AMRX
AMNEAL PHARMACEUTICALS, INC.
SALE
Executive Vice President & CFO
45,289——135,870Mar 3, 2023Mar 7, 2023 ↗View →
AMRX
AMNEAL PHARMACEUTICALS, INC.
PURCHASE
Executive Vice President & CFO
45,289——293,121Mar 3, 2023Mar 7, 2023 ↗View →
AMRX
AMNEAL PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
458,716——458,716Mar 3, 2023Mar 7, 2023 ↗View →
AMRX
AMNEAL PHARMACEUTICALS, INC.
PURCHASE
Executive Vice President & CFO
36,197——247,832Mar 1, 2023Mar 3, 2023 ↗View →
AMRX
AMNEAL PHARMACEUTICALS, INC.
SALE
Executive Vice President & CFO
36,197——72,394Mar 1, 2023Mar 3, 2023 ↗View →
AMRX
AMNEAL PHARMACEUTICALS, INC.
PURCHASE
Executive Vice President & CFO
87,719——211,635Mar 12, 2022Mar 15, 2022 ↗View →
AMRX
AMNEAL PHARMACEUTICALS, INC.
SALE
Executive Vice President & CFO
87,719——175,439Mar 12, 2022Mar 15, 2022 ↗View →
AMRX
AMNEAL PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
362,318——362,318Mar 3, 2022Mar 3, 2022 ↗View →
AMRX
AMNEAL PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
181,159——181,159Mar 3, 2022Mar 3, 2022 ↗View →
AMRX
AMNEAL PHARMACEUTICALS, INC.
PURCHASE
Executive Vice President & CFO
36,197——123,916Mar 1, 2022Mar 3, 2022 ↗View →
AMRX
AMNEAL PHARMACEUTICALS, INC.
SALE
Executive Vice President & CFO
36,197——108,591Mar 1, 2022Mar 3, 2022 ↗View →
AMRX
AMNEAL PHARMACEUTICALS, INC.
SALE
Executive Vice President & CFO
87,719——263,158Mar 12, 2021Mar 15, 2021 ↗View →
AMRX
AMNEAL PHARMACEUTICALS, INC.
PURCHASE
Executive Vice President & CFO
87,719——87,719Mar 12, 2021Mar 15, 2021 ↗View →
AMRX
AMNEAL PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
144,788——144,788Mar 1, 2021Mar 3, 2021 ↗View →
AMRX
AMNEAL PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
289,576——289,576Mar 1, 2021Mar 3, 2021 ↗View →
AMRX
AMNEAL PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
701,754——701,754Mar 12, 2020Mar 16, 2020 ↗View →
AMRX
AMNEAL PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
350,877——350,877Mar 12, 2020Mar 16, 2020 ↗View →
Other insiders · AMRX
Loading peer insiders…
About this filer
CIK 0001320982
ROLE
Executive Vice President & CFO
PRIMARY
AMRX
COMPANIES
1
ACTIVE SINCE
Mar 2020
MARKETPEEL · /INSIDER/0001320982DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

The morning brief, before the bell.

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback